[1]苏静静,王雪青,宋文军,等.普洱茶茶色素对小鼠的预防肥胖作用[J].食品工业科技, 2014, 35(19):346-350[2] SANO M, TAKENAKA Y, KOJIMA R, et al.Effects of Pu-erh tea on lipid metabolism in rats[J]. Chemical & Pharmaceutical Bulletin, 1986, 34:221-228.[J].Chemical & Pharmaceutical Bulletin, 1986, 34(1):221-228[3] QI Y, HOU I C, FUJITA H, YAZAWA K, et al.Antiobesity effects of Chinese black tea (pu-erh tea) extract and gallic acid[J]. Phytotherapy Research, 2012, 26:475-481. DOI: 10.1002/ptr.3602[J].Phytotherapy Research, 2012, 26(4):475-481[4]TANG W, LI S, LIU Y, et al.Anti-diabetic activity of chemically profiled green tea and black tea extracts in a type 2 diabetes mice model via different mechanisms[J].Journal of Functional Foods, 2013, 5(4):1784-1793[5]苏静静,王雪青,宋文军, 等.普洱茶对小鼠血糖的干预作用[J].食品科学, 2014, 35(9):260-263[6]CAO Z H, GU D H, LIN Q, et al.Effect of Pu-erh tea on body fat and lipid profiles in rats with diet-induced obesity[J].Phytotherapy Research, 2011, 25(2):234-238[7] 陈亚蓝,王雪青, 王怡雯, 等.普洱茶茶色素对HepG2细胞脂质代谢的影响及作用机理[J]. 2017, 38(17):203-209.DOI: 10.7506/spkx1002-6630-201717033[J].食品科学, 2017, 38(17):203-209[8]DEKA A, VITA J A.Tea and cardiovascular disease[J].Pharmacological Research, 2011, 64(2):136-145[9] 希雨.常饮黑茶可以保护心脏健康[J]. 国外医药(植物药分册), 2000, (05):228-229.[J].国外医药(植物药分册), 2000, 15(5):228-229[10] YANG C S, WANG H, SHERIDAN Z P.Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea[J]. Journal of Food and Drug Analysis, 2018, 26:1-13.DOI: 10.1016/j.jfda.2017.10.010[J].Journal of Food and Drug Analysis, 2018, 26(1):1-13[11]ZHAO L J, JIA S T, TANG W R, et al.Pu-erh tea inhibits tumor cell growth by down-regulating mutant p53[J].International Journal of Molecular Sciences, 2011, 12(11):7581-7793[12] LEE L K, FOO K Y.Recent advances on the beneficial use and health implications of Pu-Erh tea[J]. Food Research International, 2013, 53: 619-628. DOI:10.1016/j.foodres.2013.02.036[J].Food Research International, 2013, 53(2):619-628[13]JUGE-AUBRY C E, HUENRICHOT E, MEIER C A.Adipose tissue: a regulator of inflammation[J].Best Practice & Research Clinical Endocrinology & Metabolism, 2005, 19(4):547-566[14]LANTHER N, LECLERCQ I A.Adipose tissues as endocrine target organs[J].Best Practice & Research Clinical Gastroenterology, 2014, 28(4):545-558[15] STOLARCZYK E.Adipose tissue inflammation in obesity: a metabolic or immune response?[J]. Current Opinion in Pharmacology, 2017, 37:35-40. DOI: 10.1016/j.coph.2017.08.006[J].Current Opinion in Pharmacology, 2017, 37(12):35-40[16]KUBOTA K, SUMI S, TOJO H, et al.Improvements of mean body mass index and body weight in preobese and overweight Japanese adults with black Chinese tea (Pu-Erh) water extract[J].Nutrition Research, 2011, 31(6):421-428[17]EMANUELE D A, PEI G, LISA P et al.Lipid-related markers and cardiovascular disease prediction[J].Jama the Journal of the American Medical Association, 2012, 307(23):2499-2506[18]SUPERKO H R, PENDYALA L, WILLIAMS P T, et al.High-density lipoprotein subclasses and their relationship to cardiovascular disease[J].Journal of Clinical Lipidology, 2012, 6(6):496-523[19]JAGANATHAN R, RAVINDRAN R, DHANASEKARAN S.Emerging role of adipocytokines in type 2 diabetes as mediators of insulin resistance and cardiovascular disease. Canadian Journal of Diabetes, 2017. DOI:10.1016/j.jcjd.2017.10.040[J].Canadian Journal of Diabetes, 2017, :1-12[20]ZWICK R K, GUERRERO-JUAREZ C F, HORSLEY V, et al.Anatomical,physiological,and functional diversity of adipose tissue[J].Cell Metabolism, 2018, 27(1):68-83[21]WALSH J M, MCGOWAN C A, BYRNE J A, et al.The association between TNF-α and insulin resistance in euglycemic women[J].Cytokine, 2013, 64(1):208-212[22]PORTER M H, CUTCHINS A, FINE J B et al.Effects of TNF-α on glucose metabolism and lipolysis in adipose tissue and isolated fat-cell preparations[J].Journal of Laboratory & Clinical Medicine, 2002, 139(3):140-145[23] NAIKOO N A, DIL-AFROZE, RASOOL R, et al.Upregulation of vascular endothelial growth factor (VEGF), its role in progression and prognosis of non-small cell lung carcinoma[J]. Cancer Genetics, 2017, 216:67-73. DOI: 10.1016/j.cancergen.2017.07.005[J].Cancer Genetics, 2017, 216-217:67-73[24] ABDEL-RAHMAN O.Targeting vascular endothelial growth factor (VEGF) pathway in gastric cancer: Preclinical and clinical aspects[J]. Critical Reviews in Oncology/hematology. 2015, 93(1):18-27. DOI: 10.1016/j.critrevonc.2014.05.012[J].Critical Reviews in Oncology/hematology, 2015, 93(1):18-27[25]LOUIE S M, ROBERTS L S, NOMURA D K.Mechanisms linking obesity and cancer[J].Biochimica et Biophysica Acta, 2013, 1831(10):1499-1508[26]PALOMO J, DIETRICH D, MARTIN P, et al.The interleukin (IL)-1 cytokine family–balance between agonists and antagonists in inflammatory diseases[J].Cytokine, 2015, 76(1):25-37 |